Status:
COMPLETED
Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology
Lead Sponsor:
Air Liquide Santé International
Conditions:
Cancer
Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
In the oncology practice, The National Union of the Centres of Fight Against the Cancer recently published the Standards, Options and Recommendations for the coverage of the pains provoked during the ...
Eligibility Criteria
Inclusion
- Age \> 18 year
- OMS between 0 to 3
- Patient who has to undergo an invasive gesture or a painful care
- Absence of contra-indication to the administration of the product
Exclusion
- Patient already included in another incompatible study with this protocol
- Patient incapable of self-assessment by the EVA
- Confusional syndrome
- OMS \> 3
- Patient already included in this protocol
- Exclusion criteria linked to the product
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
204 Patients enrolled
Trial Details
Trial ID
NCT00646945
Start Date
September 1 2007
End Date
October 1 2008
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Alexis Vautrin
Vandœuvre-lès-Nancy, France, 54 500